Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-10-25 to 2023-10-26
Current total value of award: $6972.74
Description: 4562597820!QUILLIVANT XR ORAL SUSP 60ML 5MG/ML